Havrix Stungulyf, dreifa 1440 ELISA ein./ml IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

havrix stungulyf, dreifa 1440 elisa ein./ml

glaxosmithkline pharma a/s - lifrarbólguveira a (deydd) - stungulyf, dreifa - 1440 elisa ein./ml

Stamaril Stungulyfsstofn og leysir, dreifa IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

stamaril stungulyfsstofn og leysir, dreifa

sanofi pasteur* - gulusóttarveira 17d-204 stofn (lifandi, veikluð) - stungulyfsstofn og leysir, dreifa

Engerix B Stungulyf, dreifa IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

engerix b stungulyf, dreifa

glaxosmithkline pharma a/s - lifrarbólgu b yfirborðsmótefnavaki - stungulyf, dreifa

Imigran Nefúði, lausn 20 mg/skammt IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

imigran nefúði, lausn 20 mg/skammt

glaxosmithkline pharma a/s - sumatriptanum inn - nefúði, lausn - 20 mg/skammt

Latanoprost Actavis Augndropar, lausn 50 míkróg/ml IJsland - IJslands - LYFJASTOFNUN (Icelandic Medicines Agency)

latanoprost actavis augndropar, lausn 50 míkróg/ml

actavis group ptc ehf. - latanoprostum inn - augndropar, lausn - 50 míkróg/ml